NextBio and Cancer Care Institute Form Strategic Partnership Focused on Clinical Use of Genomics

SANTA CLARA, Calif.-- NextBio and Cancer Care Institute (CCI) announced today a strategic partnership aimed at furthering the adoption of genomics in the clinic. The collaboration will facilitate use of the NextBio platform to interpret genomic molecular data for oncology patients and streamline the complete workflow for use of molecular data in a clinical setting. [...]

Certara Names University of Maryland School of Pharmacy’s Center for Translational Medicine as newest Phoenix® Center of Excellence

ST. LOUIS -- Certara™, a market-leading provider of software and scientific services to improve productivity and decision-making in clinical drug development, announced today that the University of Maryland School of Pharmacy’s Center for Translational Medicine (CTM) has been named as the latest Phoenix® Center of Excellence, expanding the program created by Pharsight (now Certara), and [...]

RainDance Technologies and MLL Munich Leukemia Laboratory Collaborate on Sequence-Based Analysis of Myeloid Malignancies

LEXINGTON, Mass. AND MUNICH, Germany,– RainDance Technologies, Inc., the Digital Biology™ Company, today announced that MLL Munich Leukemia Laboratory (MLL) has purchased the company's ThunderStorm™ System and consumables to process an initial 2,000 samples for use in the identification of prognostically relevant molecular mutations associated with Acute Myeloid Leukemia (AML) and other myeloid malignancies. Additionally, [...]

Affymetrix Completes Acquisition of eBioscience Holding Company, Inc.

SANTA CLARA, Calif.-- Affymetrix Inc., (NASDAQ:AFFX) today announced that the Company has completed its acquisition of eBioscience Holding Company, Inc., a privately-held company with an industry-leading position in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics. The acquisition enhances Affymetrix’s product portfolio and expands its addressable markets by more than $2.5 [...]

DVS Sciences and Cytobank announce partnership to analyze and manage high-parameter mass cytometry data

Sunnyvale CA, and Mountain View, CA USA, – DVS Sciences, Inc., a privately held innovator and manufacturer of novel CyTOF® multi-parameter single-cell analyzers and reagents for biological research, today announced a business agreement with Cytobank, Inc., a privately held developer of cloud based scientific, informatics and software solutions for the flow cytometry market. The CyTOF [...]

BD Biosciences Launches BD FACSJazz™ Cell Sorting System

San Jose, CA – BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced the launch of the BD FACSJazz™ Cell Sorting System, a next-generation flow cytometer that simplifies cellular isolation and analysis for researchers requiring high sample integrity. Occupying 20” x 20” (51 cm x 51 cm) of benchtop space, [...]

Rapid, Reliable Isolation and Processing of Individual Cells for Genomic Analysis

Fluidigm recently unveiled the details of its new C1™ Single-Cell AutoPrep System to attendees at the International Society for Stem Cell Research (ISSCR) meeting in Yokohama, Japan. The C1 System, based on Fluidigm's innovative microfluidic technology, enables a researcher to isolate and process individual cells rapidly and reliably for genomic analysis. For the first time, [...]

NeuroTherapeutics Pharma (NTP) licenses Dotmatics’ informatics platform

Dotmatics Limited, a leading provider of scientific informatics solutions and services to the Pharmaceutical and Biotechnology industries, announces that NeuroTherapeutics Pharma, Inc has licensed and deployed the Dotmatics informatics platform. NTP’s increasing need for an informatics system, to manage their chemistry and related data, led them to assess and evaluate available solutions in the market. [...]

Agilent Technologies Completes Acquisition of Dako, Danish Cancer Diagnostics Company

Agilent Technologies Inc. (NYSE: A) today announced that its acquisition of cancer diagnostics company Dako has been completed. Agilent, which paid $2.2 billion in cash for Dako (on a debt-free basis), expects the acquisition to help strengthen Agilent's position in life sciences, with a focus on product development to help in the fight against cancer. [...]

Aushon Launches Cira™ Multiplex Protein Biomarker Platform

BILLERICA, MA – Aushon announced the launch of Cira, a new multiplex immunoassay platform that achieves the sensitivity and reproducibility of singleplex ELISA, while substantially improving ease of use and leveraging the benefits of parallel analysis. The system’s revolutionary design produces faster results at a lower cost per sample and higher throughput without compromising the [...]

Access IBO on Knowledge Center